Literature DB >> 25022538

Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease.

Katherine J Bangen1, Daniel A Nation2, Lisa Delano-Wood3, Gali H Weissberger4, Lawrence A Hansen5, Douglas R Galasko6, David P Salmon7, Mark W Bondi8.   

Abstract

We examined the relationships of antemortem vascular risk factors to postmortem cerebrovascular and Alzheimer's disease (AD) pathologies. Eighty-four AD patients underwent an assessment of vascular risk (blood pressure, cholesterol, smoking, cardiovascular disease, diabetes, atrial fibrillation, transient ischemic attack [TIA], or stroke) and later underwent brain autopsy. Given our aim to examine mild cerebrovascular changes (CVCs), individuals were excluded if autopsy revealed large stroke. The most common forms of CVC were circle of Willis atherosclerosis followed by arteriosclerosis, lacunes, and microinfarcts. Excluding the history of TIA/clinical stroke, individual vascular risk factors were not associated with CVC. However, the presence of multiple vascular risk factors was associated with CVC. Furthermore, the presence of CVC was associated with lower Braak and Braak stage. These findings highlight the importance of aggregate risk in the vascular contribution to dementia. Interventions designed to maintain cerebrovascular health may represent important opportunities for preventing or delaying dementia, even when AD is the dominant pathology. Published by Elsevier Inc.

Entities:  

Keywords:  Alzheimer's disease; Cerebrovascular disease; Dementia; Neuropathology; Vascular risk

Mesh:

Year:  2014        PMID: 25022538      PMCID: PMC4287462          DOI: 10.1016/j.jalz.2013.12.025

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  50 in total

1.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

2.  Vascular burden and Alzheimer disease pathologic progression.

Authors:  Raymond Y Lo; William J Jagust
Journal:  Neurology       Date:  2012-09-12       Impact factor: 9.910

Review 3.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

Review 4.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

6.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

7.  Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.

Authors:  Mark Yarchoan; Sharon X Xie; Mitchel A Kling; Jon B Toledo; David A Wolk; Edward B Lee; Vivianna Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Steven E Arnold
Journal:  Brain       Date:  2012-11-30       Impact factor: 13.501

8.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations.

Authors:  Ian R A Mackenzie; Manuela Neumann; Eileen H Bigio; Nigel J Cairns; Irina Alafuzoff; Jillian Kril; Gabor G Kovacs; Bernardino Ghetti; Glenda Halliday; Ida E Holm; Paul G Ince; Wouter Kamphorst; Tamas Revesz; Annemieke J M Rozemuller; Samir Kumar-Singh; Haruhiko Akiyama; Atik Baborie; Salvatore Spina; Dennis W Dickson; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2008-11-18       Impact factor: 17.088

9.  The neuropathology of older persons with and without dementia from community versus clinic cohorts.

Authors:  Julie A Schneider; Neelum T Aggarwal; Lisa Barnes; Patricia Boyle; David A Bennett
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community.

Authors:  Adam M Brickman; Frank A Provenzano; Jordan Muraskin; Jennifer J Manly; Sonja Blum; Zoltan Apa; Yaakov Stern; Truman R Brown; José A Luchsinger; Richard Mayeux
Journal:  Arch Neurol       Date:  2012-12
View more
  37 in total

1.  Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.

Authors:  Katherine J Bangen; Jayandra J Himali; Alexa S Beiser; Daniel A Nation; David J Libon; Caroline S Fox; Sudha Seshadri; Philip A Wolf; Ann C McKee; Rhoda Au; Lisa Delano-Wood
Journal:  J Alzheimers Dis       Date:  2016-07-06       Impact factor: 4.472

2.  Multimorbidity and neuroimaging biomarkers among cognitively normal persons.

Authors:  Maria Vassilaki; Jeremiah A Aakre; Michelle M Mielke; Yonas E Geda; Walter K Kremers; Rabe E Alhurani; Mary M Machulda; David S Knopman; Ronald C Petersen; Val J Lowe; Clifford R Jack; Rosebud O Roberts
Journal:  Neurology       Date:  2016-04-13       Impact factor: 9.910

3.  Neuropsychological Deficit Profiles, Vascular Risk Factors, and Neuropathological Findings in Hispanic Older Adults with Autopsy-Confirmed Alzheimer's Disease.

Authors:  Gali H Weissberger; Tamar H Gollan; Mark W Bondi; Daniel A Nation; Lawrence A Hansen; Douglas Galasko; David P Salmon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 4.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.

Authors:  Costantino Iadecola; Kristine Yaffe; José Biller; Lisa C Bratzke; Frank M Faraci; Philip B Gorelick; Martha Gulati; Hooman Kamel; David S Knopman; Lenore J Launer; Jane S Saczynski; Sudha Seshadri; Adina Zeki Al Hazzouri
Journal:  Hypertension       Date:  2016-10-10       Impact factor: 10.190

5.  Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.

Authors:  Kelsey R Thomas; Jessica R Osuna; Alexandra J Weigand; Emily C Edmonds; Alexandra L Clark; Sophia Holmqvist; Isabel H Cota; Christina E Wierenga; Mark W Bondi; Katherine J Bangen
Journal:  J Cereb Blood Flow Metab       Date:  2020-07-02       Impact factor: 6.200

6.  Relationship Between Type 2 Diabetes Mellitus and Cognitive Change in a Multiethnic Elderly Cohort.

Authors:  Katherine J Bangen; Yian Gu; Alden L Gross; Brooke C Schneider; Jeannine C Skinner; Andreana Benitez; Bonnie C Sachs; Regina Shih; Shannon Sisco; Nicole Schupf; Richard Mayeux; Jennifer J Manly; José A Luchsinger
Journal:  J Am Geriatr Soc       Date:  2015-06-11       Impact factor: 5.562

Review 7.  Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.

Authors:  Rebecca Parodi-Rullán; Je Yeong Sone; Silvia Fossati
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

8.  Cerebrovascular Damage Mediates Relations Between Aortic Stiffness and Memory.

Authors:  Leroy L Cooper; Todd Woodard; Sigurdur Sigurdsson; Mark A van Buchem; Alyssa A Torjesen; Lesley A Inker; Thor Aspelund; Gudny Eiriksdottir; Tamara B Harris; Vilmundur Gudnason; Lenore J Launer; Gary F Mitchell
Journal:  Hypertension       Date:  2015-11-16       Impact factor: 10.190

Review 9.  The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline.

Authors:  Roderick A Corriveau; Francesca Bosetti; Marian Emr; Jordan T Gladman; James I Koenig; Claudia S Moy; Katherine Pahigiannis; Salina P Waddy; Walter Koroshetz
Journal:  Cell Mol Neurobiol       Date:  2016-04-19       Impact factor: 5.046

10.  Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.

Authors:  Katherine J Bangen; Alexandra L Clark; Madeline Werhane; Emily C Edmonds; Daniel A Nation; Nicole Evangelista; David J Libon; Mark W Bondi; Lisa Delano-Wood
Journal:  J Alzheimers Dis       Date:  2016-03-29       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.